~8 spots leftby Dec 2025

Dietary Interventions for Diabetes Prevention

MS
DP
AC
CB
Overseen ByCaroline Bejikian, BS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Stanford University
Must not be taking: Diabetogenic, Weight loss
Disqualifiers: Major organ disease, Hypertension, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to prevent diabetes by creating personalized diet plans based on individual differences in how people develop the disease. It focuses on people with pre-diabetes or diabetes and uses biomarkers to diagnose and tailor diets early.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are on diabetogenic medications (medications that can cause diabetes), you may not be eligible to participate.

What data supports the effectiveness of the treatment Precision Diets, Personalized Nutrition, Precision Nutrition for diabetes prevention?

Research suggests that precision nutrition, which tailors dietary advice based on individual characteristics like genetics and metabolism, can potentially be more effective in preventing type 2 diabetes compared to traditional approaches. Studies have shown that personalized dietary interventions can improve glycemic control (blood sugar management) and help manage risk factors for diabetes.12345

Is precision nutrition safe for humans?

The research on precision nutrition, which tailors dietary advice based on individual characteristics like genetics and metabolism, does not report any specific safety concerns for humans. However, more studies are needed to confirm its safety and effectiveness compared to traditional nutrition approaches.23678

How does the treatment Precision Diets differ from other treatments for diabetes prevention?

Precision Diets, or Precision Nutrition, is unique because it tailors dietary recommendations to an individual's genetic background, metabolic profile, and gut microbiome, unlike traditional one-size-fits-all approaches. This personalized strategy aims to optimize dietary response and improve health outcomes by considering personal characteristics and using advanced technologies like genomics and metabolomics.2391011

Research Team

Tracey McLaughlin | Stanford Medicine

Tracey L McLaughlin, MD

Principal Investigator

Stanford University

MP

Michael P Snyder, PhD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for adults over 18 who are not pregnant and do not have any major organ diseases, uncontrolled high blood pressure, or conditions affecting nutrient absorption like celiac disease. It's also important that participants haven't had significant weight changes recently, aren't heavy alcohol users, don't use weight loss drugs or follow specific diets, and haven't undergone bariatric surgery.

Inclusion Criteria

Not be pregnant, if female;
I am 18 years old or older.

Exclusion Criteria

Any medical condition that physicians believe would interfere with study participation or evaluation of results.
I am mentally capable and can understand and follow the study's requirements.
I do not have major organ disease, uncontrolled high blood pressure, am not pregnant or breastfeeding, do not use certain medications, and have not had significant weight changes or surgery for weight loss.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Metabolic Testing

Participants undergo metabolic tests including the Oral Glucose Tolerance Test, Insulin Sensitivity Test, and Isoglycemic Intravenous Glucose Infusion

4-8 weeks
3 visits (in-person)

Dietary Monitoring

Participants follow their own diet while using the CGM and test standardized foods

8-12 weeks
2 visits (in-person), 1 visit (virtual)

Dietary Counseling

Participants are counseled on reducing foods that cause glucose spikes and on macronutrient composition

8-12 weeks
2 visits (in-person)

Follow-up

Participants are monitored for changes in glycemic control and metabolic subphenotype classification

3 years

Treatment Details

Interventions

  • Precision Diets (N/A)
Trial OverviewThe study aims to understand how different people develop pre-diabetes and diabetes by looking at their individual physiological differences. Researchers will try to find biomarkers for early diagnosis and create personalized diet plans to prevent the onset of diabetes more effectively.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Optimizing Diet for Glycemic ControlExperimental Treatment1 Intervention
Phase 1: Metabolic testing will include 3 metabolic tests: 1. The Oral Glucose Tolerance Test. The participant will wear the CGM while undergoing the OGTT + will be asked to repeat the test at home twice. 2. The Insulin Sensitivity Test (Steady State Plasma Glucose). This test is designed to measure how well cells remove glucose from the blood in response to insulin. 3. The Isoglycemic Intravenous Glucose Infusion (IIGI). This test is designed to measure the incretin hormone effect. Phase 2: Participants follow their own diet while using the CGM. Participants are provided with 5-10 standardized foods to test during this phase. Phase 3: Participants are provided with additional standardized foods and counseled to continue their own diet during this phase. Phase 4: Participants are counseled on reducing or limiting the foods that caused glucose spikes and they are also counseled on macronutrient composition of their diet based on lipid profile.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Human Genome Research Institute (NHGRI)

Collaborator

Trials
273
Recruited
299,000+

Findings from Research

In a study of 136 Japanese adults with type 2 diabetes, individualized dietary advice led to a greater reduction in HbA1c levels (-1.1%) compared to conventional dietary advice (-0.7%) over 6 months, indicating its effectiveness in managing blood sugar levels.
Participants receiving individualized advice also made healthier dietary changes, such as reducing energy intake and consumption of sweets and fats, which contributed to improvements in weight and lipid profiles, although these changes were not significantly different from the conventional group.
Effects of individualized dietary advice compared with conventional dietary advice for adults with type 2 diabetes: A randomized controlled trial.Omura, Y., Murakami, K., Matoba, K., et al.[2022]
Precision nutrition, which tailors dietary recommendations based on an individual's genetics, metabolism, and environment, shows promise in preventing and managing type 2 diabetes through personalized dietary interventions.
Despite advances in technology and research, the field faces challenges such as high costs, methodological issues, and the need for more robust evidence to support its efficacy compared to traditional nutrition strategies.
Precision nutrition for prevention and management of type 2 diabetes.Wang, DD., Hu, FB.[2022]
Precision nutrition, which tailors dietary recommendations based on individual characteristics like genetics and metabolism, shows significant promise in effectively improving risk factors for obesity and type 2 diabetes, as highlighted by recent research.
This approach addresses the limitations of traditional dietary interventions by providing personalized strategies that can lead to better behavior change and health outcomes, suggesting it could be a more effective alternative in managing these chronic conditions.
Precision Nutrition to Improve Risk Factors of Obesity and Type 2 Diabetes.Antwi, J.[2023]

References

Effects of individualized dietary advice compared with conventional dietary advice for adults with type 2 diabetes: A randomized controlled trial. [2022]
Precision nutrition for prevention and management of type 2 diabetes. [2022]
Precision Nutrition to Improve Risk Factors of Obesity and Type 2 Diabetes. [2023]
Research charting a course for evidence-based clinical dietetic practice in diabetes. [2010]
Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. [2019]
Does Personalized Nutrition Advice Improve Dietary Intake in Healthy Adults? A Systematic Review of Randomized Controlled Trials. [2023]
Harnessing the gut microbiota to promote metabolic health. [2021]
A study protocol for a pilot randomized controlled trial to evaluate the effectiveness of a gene-based nutrition and lifestyle recommendation for weight management among adults: the MyGeneMyDiet® study. [2023]
[Precision nutrition: handle with care.] [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Addressing the Nutritional Phenotype Through Personalized Nutrition for Chronic Disease Prevention and Management. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Research navigating the course of clinical practice in diabetes. [2005]